The Structural Genomics Consortium: A knowledge platform for drug discovery

doi:10.7249/RR512

GSTDTAP > 资源环境科学

DOI	10.7249/RR512
报告编号	RR-512-SGC
	The Structural Genomics Consortium: A knowledge platform for drug discovery
	Molly Morgan Jones; Sophie Castle-Clarke; Daniel Brooker; Edward Nason; Farah Huzair; Joanna Chataway
	2014
出版年	2014
页数	114
语种	英语
国家	美国
出版者	RAND Corporation
领域	资源环境
英文摘要	The Structural Genomics Consortium (SGC) supports drug discovery efforts through a unique, open access model of public-private collaboration. This report presents the results of an independent evaluation of the Structural Genomics Consortium, conducted by RAND Europe with the Institute on Governance. The evaluation aimed to establish the role of the SGC within the wider drug discovery and public-private partnership (PPP) landscape, assessing the merits of the SGC open access model relative to alternative models of funding R&D in this space, as well as the key trends and opportunities in the external environment that may impact on the future of the SGC. It also established the incentives and disincentives for investment, strengths and weaknesses of the SGC's model, and the opportunities and threats the SGC will face in the future. This enabled us to assess the most convincing arguments for funding the SGC at present; important trade-offs or limitations that should be addressed in moving towards the next funding phase; and whether funders are anticipating changes either to the SGC or the wider PPP landscape. Finally, we undertook a quantitative analysis to ascertain what judgements can be made about the SGC's past and current performance track record, before unpacking the role of the external environment and particular actors within the SGC in developing scenarios for the future.
英文关键词	Genomic Medicine Biotechnology Intellectual Property Science, Technology and Innovation Policy Pharmaceutical Drugs
URL	查看原文
来源平台	Rand Corporation
引用统计
文献类型	科技报告
条目标识符	http://119.78.100.173/C666/handle/2XK7JSWQ/3990
专题	资源环境科学
推荐引用方式 GB/T 7714	Molly Morgan Jones,Sophie Castle-Clarke,Daniel Brooker,et al. The Structural Genomics Consortium: A knowledge platform for drug discovery:RAND Corporation,2014.